Biofrontera (BFRI) Restructuring Costs (2021)

Biofrontera (BFRI) posted quarterly Restructuring Costs of $98000.0 for Q4 2021, down 50.75% quarter-over-quarter from $199000.0 in Q3 2021.

Biofrontera (BFRI) Restructuring Costs (2021) Analysis & Trends

Biofrontera's Restructuring Costs history runs 1 years deep, the most recent figure standing at $98000.0 for Q4 2021.

In Q4 2021, Restructuring Costs changed N/A year-over-year to $98000.0; the TTM figure through Dec 2021 stood at $764000.0 (changed N/A YoY), while the FY2021 annual figure was $752000.0, down 33.57% from the prior year.
Restructuring Costs for Q4 2021 stood at $98000.0, down from $199000.0 in the prior quarter.
The five-year high for Restructuring Costs was $281000.0 in Q1 2021, with the low at $98000.0 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-
2	Teva Pharmaceutical Industries	43.07 Bn	39.42 Bn	2.15 Bn
3	Zoetis	31.53 Bn	29.85 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.60 Bn	22.80 Bn	5.10 Bn
5	United Therapeutics	22.13 Bn	19.47 Bn	683.80 Mn
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn
8	Elanco Animal Health	11.69 Bn	11.16 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.13 Bn	9.97 Bn	-
10	Biofrontera	18.35 Mn	13.64 Mn	9.59 Mn

Download Data